RFX5 Antikörper (C-Term)
-
- Target Alle RFX5 Antikörper anzeigen
- RFX5 (Regulatory Factor X 5 (RFX5))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RFX5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-RFX5 Antibody, Affinity Purified
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 575 and C-term
- Isotyp
- IgG
- Top Product
- Discover our top product RFX5 Primärantikörper
-
-
- Applikationshinweise
-
IP: 1 - 4 μg/mg lysate
WB: 1:500 - 1:5,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- RFX5 (Regulatory Factor X 5 (RFX5))
- Andere Bezeichnung
- RFX5 (RFX5 Produkte)
- Synonyme
- regulatory factor X5 antikoerper, regulatory factor X, 5 (influences HLA class II expression) antikoerper, RFX5 antikoerper, Rfx5 antikoerper
- Hintergrund
- Background: Regulatory factor X-5 (RFX5) is a 75 kDa subunit of the regulatory factor X (RFX) heteromeric complex that activates the transcription of major histocompatibility class II (MHC-II) genes by binding MHC-II promoter elements. The RFX complex consists of RFX5, RFXANK, and RFXAP. Mutations in these genes result in a lack of MHCII transcription and lead to the severe combined immunodeficiency disease, Bare Lymphocyte Syndrome (BLS).
- Gen-ID
- 5993
- NCBI Accession
- NP_000440
- UniProt
- P48382
-